In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer
dc.contributor.author | Mijit, M. | |
dc.contributor.author | Kpenu, E. | |
dc.contributor.author | Chowdhury, N. N. | |
dc.contributor.author | Gampala, S. | |
dc.contributor.author | Wireman, R. | |
dc.contributor.author | Liu, S. | |
dc.contributor.author | Babb, O. | |
dc.contributor.author | Georgiadis, M. M. | |
dc.contributor.author | Wan, J. | |
dc.contributor.author | Fishel, M. L. | |
dc.contributor.author | Kelley, M. R. | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2024-05-09T10:30:22Z | |
dc.date.available | 2024-05-09T10:30:22Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Ref-1/APE1 (Redox Effector/Apurinic Endonuclease 1) is a multifunctional enzyme that serves as a redox factor for several transcription factors (TFs), e.g., NF-kB, HIF-1α, which in an oxidized state fail to bind DNA. Conversion of these TFs to a reduced state serves to regulate various biological responses such as cell growth, inflammation, and cellular metabolism. The redox activity involves a thiol exchange reaction for which Cys65 (C65) serves as the nucleophile. Using CRISPR editing in human pancreatic ductal adenocarcinoma (PDAC) cells, we changed C65 to Ala (C65A) in Ref-1 to evaluate alteration of Ref-1 redox dynamics as well as chronic loss of Ref-1 redox activity on cell signaling pathways, specifically those regulated by NF-kB and HIF-1α. The redox activity of Ref-1 requires partial unfolding to expose C65, which is buried in the folded structure. Labeling of Ref-1 with polyethylene glycol-maleimide (PEGm) provides a readout of reduced Cys residues in Ref-1 and thereby an assessment of partial unfolding in Ref-1. In comparing Ref-1WT vs Ref-1C65A cell lines, we found an altered distribution of oxidized versus reduced states of Ref-1. Accordingly, activation of NF-kB and HIF-1α in Ref-1C65A lines was significantly lower compared to Ref-1WT lines. The bioinformatic data revealed significant downregulation of metabolic pathways including OXPHOS in Ref-1C65A expressing clones compared to Ref-1WT line. Ref-1C65A also demonstrated reduced cell proliferation and use of tricarboxylic acid (TCA) substrates compared to Ref-1WT lines. A subcutaneous as well as PDAC orthotopic in vivo model demonstrated a significant reduction in tumor size, weight, and growth in the Ref-1C65A lines compared to the Ref-1WT lines. Moreover, mice implanted with Ref-1C65A redox deficient cells demonstrate significantly reduced metastatic burden to liver and lung compared to mice implanted with Ref-1 redox proficient cells. These results from the current study provide direct evidence that the chronic absence of Cys65 in Ref-1 results in redox inactivity of the protein in human PDAC cells, and subsequent biological results confirm a critical involvement of Ref-1 redox signaling and tumorigenic phenotype. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Mijit M, Kpenu E, Chowdhury NN, et al. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer. Redox Biol. 2024;69:102977. doi:10.1016/j.redox.2023.102977 | |
dc.identifier.uri | https://hdl.handle.net/1805/40583 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1016/j.redox.2023.102977 | |
dc.relation.journal | Redox Biology | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | PMC | |
dc.subject | Ref-1/APE1 | |
dc.subject | Transcription factors (TFs) | |
dc.subject | PDAC | |
dc.subject | Redox | |
dc.subject | NF-kB | |
dc.subject | HIF-1α | |
dc.title | In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer | |
dc.type | Article |